Evidence mapPaperPMID 40329411Full record

ArticleSchizophrenia bulletin2026

Mental Health Professionals' Perspectives on Digital Remote Monitoring in Services for People with Psychosis.

Hannah Ball, Emily Eisner, John Ainsworth, Eloise Bagg, Louise Beattie, Matteo Cella, Natalie Chalmers, Sybil Clifford, Richard J Drake, Sophie Faulkner and 25 more

Abstract read
In one paragraph

Article in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Hannah BallDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Emily EisnerDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
John AinsworthDivision of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, School of Health Sciences, University of Manchester, Manchester, United Kingdom.
Eloise BaggMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Louise BeattieSchool of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Matteo CellaDepartment of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID 0000-0002-5701-0336
Natalie ChalmersSchool of Health in Social Science, University of Edinburgh, Edinburgh, United Kingdom.
Sybil CliffordSchool of Psychology, University of Sussex, Falmer, United Kingdom.
Richard J DrakeDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.ORCID 0000-0003-0220-4835
Sophie FaulknerDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Kathryn GreenwoodSchool of Psychology, University of Sussex, Falmer, United Kingdom.
Andrew GumleySchool of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Gillian HaddockDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Kimberley M KendallMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Alex KennyThe McPin Foundation, London, United Kingdom.
Jane LeesDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Shôn LewisDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Laura MacleanSchool of Health in Social Science, University of Edinburgh, Edinburgh, United Kingdom.
Jennifer NicholasCentre for Youth Mental Health, University of Melbourne, Melbourne, Australia.
Kathryn O'HareSchool of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Anuoluwapo OluwatayoDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Sandapa PunchihewaMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Cara RichardsonDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Leonie RichardsonSchool of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
Matthias SchwannauerSchool of Health in Social Science, University of Edinburgh, Edinburgh, United Kingdom.
Joseph SherborneResearch and Development Department, Sussex Partnership NHS Foundation Trust, Hove, United Kingdom.
Rebecca TurnerDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.ORCID 0000-0002-0480-4626
Evelin VogelResearch and Development Department, Sussex Partnership NHS Foundation Trust, Hove, United Kingdom.
James WaltersMRC Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, United Kingdom.
Alice WarnerResearch and Development Department, Sussex Partnership NHS Foundation Trust, Hove, United Kingdom.
Paul WilsonCentre for Primary Care and Health Services Research, Division of Population Health, The University of Manchester, Manchester, United Kingdom.
Til WykesDepartment of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID 0000-0002-5881-8003
Uzma ZahidDepartment of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.ORCID 0000-0002-7849-4907
Xiaolong ZhangDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.
Sandra BucciDivision of Psychology and Mental Health, Faculty of Biology, Medicine and Health, Manchester Academic Health Sciences, The University of Manchester, School of Health Sciences, Manchester, United Kingdom.

Funding

National Institute for Health and Care Research NIHR 300794NIHR Manchester Biomedical Research Centre NIHR203308NIHR Maudsley Biomedical Research Centre NIHR203318Wellcome grant 222875/Z/21/ZWellcome Trust
6 · The paper itself

Abstract

background and hypothesisDigital remote monitoring (DRM) captures service users' health-related data remotely using devices such as smartphones and wearables. Data can be analyzed using advanced statistical methods (eg, machine learning) and shared with clinicians to aid assessment of people with psychosis' mental health, enabling timely intervention. Such methods show promise in detecting early signs of psychosis relapse. However, little is known about clinicians' views on the use of DRM for psychosis. This study explores multi-disciplinary staff perspectives on using DRM in practice. STUDY

designFifty-nine mental health professionals were interviewed about their views on DRM in psychosis care. Interviews were analyzed using reflexive thematic analysis. Study Results: Five overarching themes were developed, each with subthemes: (1) the perceived value of digital remote monitoring; (2) clinicians' trust in digital remote monitoring (3 subthemes); (3) service user factors (2 subthemes); (4) the technology-service user-clinician interface (2 subthemes); and (5) organizational context (2 subthemes).

conclusionsParticipants saw the value of using DRM to detect early signs of relapse and to encourage service user self-reflection on symptoms. However, the accuracy of data collected, the impact of remote monitoring on therapeutic relationships, data privacy, and workload, responsibility and resource implications were key concerns. Policies and guidelines outlining clinicians' roles in relation to DRM and comprehensive training on its use are essential to support its implementation in practice. Further evaluation regarding the impact of digital remote monitoring on service user outcomes, therapeutic relationships, clinical workflows, and service costs is needed.

Indexed as

Attitude of Health PersonnelHealth PersonnelMental Health ServicesPsychotic DisordersTelemedicineAdultFemaleHumansMaleMiddle AgedQualitative ResearchWearable Electronic Devicesactive symptom monitoringmachine learningpassive sensingrelapse predictionstaff views

Identifiers

PMID40329411
PMCPMC12809784

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.